Forbes -
8 Jul 2013 17:45

Looking back to 61 days ago, Isis Pharmaceuticals, Inc. (NASD: ISIS) priced a 9,000,000 share secondary stock offering at $19.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 56% higher than the offering price.
Share this Article
Comment on this Article
Please to comment